Smoking and inflammatory bowel disease

D. T. Rubin, S. B. Hanauer*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

97 Scopus citations


It is well established that smoking cigarettes is associated with Crohn's disease (CD) and that non-smoking is associated with ulcerative colitis (UC). Furthermore, there is convincing evidence that smoking cigarettes has a negative effect on the course of CD, and that smoking cigarettes may improve the disease severity or have a 'protective' effect in some patients with UC. Despite these well-described associations, the mechanism by which cigarette smoking affects CD and UC is not known. Researchers have studied the systemic effects, cellular and humoral immune effects, mucosal changes, and the intestinal permeability changes with inflammatory bowel disease (IBD) and smoking. To date, none of these studies adequately explains the observed clinical patterns. It has been assumed that nicotine is the active agent in these associations, but clinical trials of nicotine chewing gum and transdermal nicotine in UC have shown limited benefit, and have been complicated by significant side-effects. Topical delivery systems for nicotine therapy are currently under development and await future clinical trials. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)855-862
Number of pages8
JournalEuropean Journal of Gastroenterology and Hepatology
Issue number8
StatePublished - 2000


  • Crohn's disease
  • Inflammatory bowel disease
  • Smoking
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Smoking and inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this